AceLink Therapeutics, Inc., a clinical-stage biotech company developing next-generation oral substrate reduction therapies (SRTs), presented interim d ...
Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis
KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...
A total of 19 physicians at Mercy Medical Center representing 11 different specialties have been named "Top Doctors" by Castle Connolly Medical Ltd. "Mercy providers continue to earn accolades for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback